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Objective: Skin and ear infections, primarily caused by Pseudomonas aeruginosa (P. aeruginosa), are recurrent
problems for saturation divers, whereas infections caused by P. aeruginosa are seldom observed in healthy
people outside saturation chambers. Cystic fibrosis (CF) patients suffer from pulmonary infections by
P. aeruginosa, and it has been demonstrated that CF patients have high levels of autoantibodies against Heat
shock protein 60 (HSP60) compared to controls, probably due to cross-reacting antibodies induced by
P. aeruginosa. The present study investigated whether rats immunised with P. aeruginosa produced
autoantibodies against their own HSP60 and whether diving influenced the level of circulating anti-HSP60
antibodies.
Methods: A total of 24 rats were randomly assigned to one of three groups (‘immunised’, ‘dived’ and
‘immunised and dived’).The rats in group 1 and 3 were immunised with the bacteria P. aeruginosa, every other
week. Groups 2 and 3 were exposed to simulated air dives to 400 kPa (4 ata) with 45 min bottom time, every
week for 7 weeks. Immediately after surfacing, the rats were anaesthetised and blood was collected from the
saphenous vein. The amount of anti-HSP60 rat antibodies in the serum was analysed by enzyme linked
immunosorbent assay.
Results: The immunised rats (group 1) showed a significant increase in the level of autoantibodies against
HSP60, whereas no autoantibodies were detected in the dived rats (group 2). The rats both immunised and
dived (group 3) show no significant increase in circulating autoantibodies against HSP60. A possible
explanation may be that HSP60 is expressed during diving and that cross-reacting antibodies are bound.
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S
aturation diving is widely used in the North Sea for
maintenance and inspection of off-shore sub-sea
petroleum production systems. Exposure to hyper-
baric environments is associated with a risk of developing
decompression sickness (DCS), arterial gas embolism,
neurological symptoms and pulmonary dysfunctions
(13). Divers are usually compressed in their working
and living environment for 1224 days and are exposed to
an ambient pressure of 0.62.1 MPa (50200 msw). The
hyperbaric working and living environment is warm and
humid and so maintains a rich microbial flora (4).
Health problems, such as skin and ear infections, in
divers working on the Norwegian Continental Shelf have
been systematically registered since 1985 (4). Within the
period from 1990 to 2010, four incidents of DCS and 201
incidents of outer ear infection were reported to the
Petroleum Safety Authority Norway (5).
Skin and ear infections in saturation diving are usually
caused by Pseudomonas aeruginosa (P. aeruginosa) (6).
Such infections have been common since the beginning of
saturation diving, and infectious outbreaks have caused
costly breaks in operations (7, 8). The P. aeruginosa
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bacterium is commonly found all over the world,
occurring in both fresh- and seawater, soil and on plants,
and the species is noted for its metabolic versatility and
its exceptional ability to adapt to and colonise various
ecological niches.
Infections caused by P. aeruginosa are seldom observed
in healthy people outside a saturation chamber, but the
bacterium is well known as an opportunistic pathogen.
Patients with cystic fibrosis (CF) suffer recurrently from
pulmonary infections due to P. aeruginosa (9). Insulin-
dependent diabetes is the most prevalent co-morbidity
condition in CF (10), and it has been suggested that
destruction of the insulin-producing beta-cells in the
pancreas is caused by autoantibodies that act against
heat shock protein 60 (HSP60) (11). HSP60 molecules are
highly phylogenetically conserved with about 50% se-
quence homology between human HSP60s and those of
P. aeruginosa (12). Thus, the presence of autoantibodies
against HSP60 in patients with CF may be due to human
antibodies cross-reacting in a process induced by the
presence of bacterial HSP60.
Heat shock proteins are involved in folding and
unfolding of other proteins (13) and are expressed in
response to various stressors such as hyperoxia, hypoxia,
heat, cold, exercise, some heavy metals and drugs, and
many of these factors are involved in diving (14). HSP60,
a member of this family, is highly expressed in vitro in
endothelial cells. It is normally an intracellular protein,
but in response to various stresses it is expressed on the
surface (15). Binding of anti-HSP60 antibodies to HSP60
has been suggested to be present in the development of
atherosclerosis (16). Furthermore, immunisation of mice
with human sera containing high levels of anti-HSP60
induces atherosclerosis (17). They even found a marked
induction of atherosclerotic lesions after a single injection
of purified anti-HSP antibodies (17).
Hence, a relevant question is whether P. aeruginosa
infections amongst saturation divers may induce produc-
tion of autoantibodies that might cross-react and bind to
human HSP60.
In the present study, we investigated whether rats
immunised with P. aeruginosa produced autoantibodies
against rat HSP60 and whether the autoantibody level
was affected by diving.
Material and methods
A total of 24 young female SpragueDawley albino rats
(Scanbur, Denmark), weighing 0.26290.013 kg, were used
in the experiment. All animals used in the experiment were
bought at the same time, from the same supplier and had
equal amount of time for acclimatisation. All experimen-
tal procedures and the care of experimental animals
conformed to the European Convention for the Protection
of Vertebrate Animals Used for Experimental and Other
Scientific Purposes, and the protocol was approved by the
Norwegian Council for Animal Research.
Following 1 week of acclimatisation, the rats were
randomly assigned to one of three groups, ‘Immunised’,
‘Dived’ and ‘Immunised and dived’ (n8 for each
group). There was no significant difference in weight
between the groups.
One strain of P. aeruginosa (genotype E) isolated from
an infected saturation diver was used in this study (4).
The isolated bacterium was inactivated by 658C for 30
min. Cultures were solved in sterile and filtered phos-
phate buffered saline (PBS) buffer (pH 7.2) and diluted to
fit optical density (OD) of 600 nm To ensure that the
vaccine is sterile, growth was examined by coating 100ml
of the vaccine on Blood Agar and incubating at 378C for
2 days. The vaccine was preserved in aliquots at 808C
until vaccinations.
The rats in groups 1 and 3 were immunised with
P. aeruginosa crude antigen, 0.2 ml every other week,
from week 1 to week 9, in total five times. Two weeks
after the first immunisation, groups 2 and 3 were exposed
to simulated air dives. The rats only subjected to pressure
exposure had injections of saline solution (0.9% NaCl,
B. Braun, Melsungen, Germany), at the same time as the
other ones had immunisations. The compressions were
performed in a 20-L hyperbaric chamber with continuous
air supply. Both dive groups were compressed (200 kPa/
min) to 400 kPa (4 ata) with 45 min bottom time. The
decompression rate was 50 kPa/min. The dive protocol in
both groups was repeated every seventh day for 7 weeks,
in total seven times.
Immediately after surfacing, the rats were anaesthe-
tised with a subcutaneous injection of a mixture of
Haldol 0.33 mg, Fentanyl 0.05 mg and Midazolan 0.5 mg
at a dose of 2.5 ml/kg of body weight. Blood was
collected from the saphenous vein. After blood sampling,
the rats were moved to their housing facilities where they
were allowed to recover.
Two weeks after the last test protocol was performed,
the rats received a 1.2-ml subcutaneous injection of the
same anaesthetic mixture as described previously and
were sacrificed by heart puncture.
Serological analyses: Enzyme linked immunosorbent
assay (ELISA) for detecting antibodies against rat
HSP60.
Sera were analysed by indirect ELISA. Recombinant
rat HSP60 (Stressgen, Victoria, Canada) was diluted at
a ratio of 1:1,000 in coating buffer, which contained
1.59 g of Na2CO3, 2.93 g of NaHCO3 and 1 L of
distilled water (pH 9.6), and 100ml/well were incubated
in microplates (Sterilin) overnight at room temperature.
Plates were then washed three times with PBS contain-
ing 0.05% Tween 20 (PBS-T). Plates were pre-incubated
at room temperature with 300 ml/well of blocking
buffer, containing 1% skimmed milk powder (Molico,
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Nestle`) in PBS, for 30 min. After washing three times
with PBS-T, wells were incubated in duplicate with rat
serum in a dilution of 1:10 ml/well, in blocking buffer,
for 2 h. Plates were washed three times with PBS-T and
incubated with polyclonal rabbit anti-rat IgG/ HRP
(DakoCytomation, Denmark), diluted at a ratio of
1:1,000 in blocking buffer, for 1 h at room temperature.
After washing four times with PBS-T, 100 ml of
freshly made Sigmafast OPD (containing 0.4 mg/ml
o-phenylenediamine, 0.4 mg/ml urea hydrogen peroxide
and 0.05 M phosphate-citrate in 20 ml distilled water, pH
5.0) (Sigma, USA) was added to each well. After
30 min, the reaction was stopped with 50 ml of 2 M
H2SO4 and plates were read at 490 nm. OD values were
derived from duplicate determinations.
Statistics
The results are presented as mean9S.D. MannWhitney
and the Wilcoxon signed-rank test were used to analyse
the ELISA results. The level of statistical significance
was set at PB0.05. All statistical analyses were per-
formed using SPSS 14.0 (SPSS Inc., Chicago, Illinois,
USA).
Results
The results from the ELISA measurements of anti-
HSP60 antibodies in serum are shown in Figs 1, 2
and 3. In the immunised group (group 1), there was a
significant increase in anti-HSP60 level from week 1 to
week 11 (p 5 0.01) (Fig. 1). No significant increase in the
concentration of free anti-HSP60 antibodies was detected
in the diving group (group 2, Fig. 2) or in the immunised
and dived group (group 3, Fig. 3). There are significantly
higher levels of anti-HSP60 at week 9 (p0.011) and 11
(p0.006) in group 1, compared to group 3.
Fig. 1. Longitudinal study of anti-HSP60 level in serum in
the immunised group (group 1). Bars represent level of anti-
HSP60 analysed by ELISA in blood samples taken every other
week, before each immunisation. Notes: **There is a significant
increase in anti-HSP60 level from week 1 to week 11 (pB0.01).
Bars represented by * are significantly different from same week
in group 3 (Fig. 3). Results are presented as mean optical density
(OD) values measured at 490 nm. The vertical lines represent the
standard deviation.
Fig. 2. Longitudinal study of anti-HSP60 level in serum in the
dived group (group 2). Notes: Bars represent level of anti-
HSP60 analysed by ELISA in blood samples taken every other
week/dive, immediately after surfacing/decompression. There is
no change in circulating anti-HSP60. Results are presented
as mean OD values measured at 490 nm. The vertical lines
represent the standard deviation.
Fig. 3. Longitudinal study of anti-HSP60 level in serum in the
immunised and dived group (group 3). Notes: Bars represent
level of anti-HSP60 analysed by ELISA in blood samples taken
every other week/dive immediately after surfacing/decompres-
sion. In contrast to the immunised rats (group 1), there is no
significant change in level of circulating anti-HSP60.Bars
represented by * are significantly different from same week in
group 1 (Fig. 1). Results are presented as mean OD values
measured at 490 nm. The vertical lines represent the standard
deviation.
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Discussion
This study demonstrates that the level of circulating
autoantibodies against HSP60 significantly increases
over time in rats with repeated immunisations with
P. aeruginosa (group 1). The dive rats (group 2) did not
show any increase in the level of circulating antibodies
during the experimental period, but more surprisingly, we
were not able to detect circulating autoantibodies against
HSP60 in immunised rats when the blood sample was
taken immediately after diving (group 3).
The increased level of autoantibodies against HSP60 in
the immunised rats in the current study is in accordance
with the situation seen in patients infected by the bacteria
P. aeruginosa (18). High levels of HSP60 autoantibodies
are associated with an increased risk of coronary heart
disease (19, 20) and have been associated with the
development of type-1 diabetes in CF patients (11).
The animals only subjected to pressure did not show
any increased level of circulating autoantibodies against
HSP60. Hence, the pressure exposures did not themselves
produce circulating autoantibodies.
When rats immunised with P. aeruginosa were exposed
to dives, they were not observed to have the same rise in
the level of circulating antibodies against HSP60 com-
pared to the immunised, non-diving rats. One possible
explanation for this may be that diving suppresses the
immune response. An alternative explanation may be that
HSP60 molecules are expressed on endothelial cells in
such a way that the cross-reacting epitopes are exposed to
the surface and, thus, enable binding between circulating
anti-HSP antibodies and exposed HSP60 epitopes.
There is considerable research on cross-reacting auto-
antibodies in relation to development of atherosclerosis
and in relation to several pathological reactions in CF
patients. Bindings between anti-HSP60 antibodies to
HSP60 have been demonstrated (16), and such bindings
may in turn give rise to inflammatory reactions
(11, 1824).
We are not aware of any studies evaluating level of
autoantibodies against HSP60 in saturation divers. Ob-
servations in the present study of higher autoantibody
level after combining bacterial exposure and diving point
in the direction of having cross-reacting autoantibodies.
Hence, it seems likely that the exposure to P. aeruginosa
in the diving environment and recurrent skin infections
(6) may give rise to production of autoantibodies against
HSP60.
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